Cardiology 2023 | Thailand | Thailand | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Exhibiting the New Perception of Heart Disease and Heart Failure

- Cardiology 2023

Regarding the Conference

Allied Academies upgrading to the next step in the world, "7th International Conference on Cardiology, Heart Disease, and Heart Failure", which will be held May 11-13, 2023, with great pleasure and honor. Cardiology 2023 provides a fantastic platform for cardiologists, researchers, scientists, academics, and others working in the field of cardiology. Cardiologists are experts in a variety of subjects with which we deal on a daily basis. We hope to bring together amazing authors to present research-based talks on a variety of themes in order to promote learning, inspiration, and meaningful discussion. The goal of this conference is to provide an innovative and comprehensive overview of the most recent research developments in all areas of cardiology. Congress will allow enough time for one-on-one meetings as well.

Insights:

The gathering of international experts and investigators to discuss current situations and case studies, future innovations, and improvements on the topic of Heart Failure and Heart Diseases will be a highlight of Cardiology 2023. All of the selected sessions will have sub-sessions to help make the two-day conference more understandable and to ensure that all of the important information is covered in some way. Because Cardiology 2023 will take place over two days, the sessions will be focused on cardiology and related topics.

Significance and Scope:

The main goal of this conference is to disseminate scientific and medicinal research and ideas about heart-related problems, which include a variety of disorders, throughout the world in order to improve understanding. We promote webinars like Cardiology 2023 to raise global awareness about cardiac conditions through international decisions and discussions that will result in extraordinary solutions to existing heart and related health problems. Cardiology 2023 also promotes advanced devices and tools that can be used to reduce the number of heart diseases that occur around the world, providing exciting business opportunities to the new market in the healthcare sector. Cardiac disorders come in a variety of forms, necessitating more medication than ever before.

International Networking

Cardiology is a huge topic, and researchers are focusing their efforts on developing new ideas and improving current methods for treating heart diseases. This is a once-in-a-lifetime opportunity to meet great people from all over the world who are experts in cardiology and to have breakout sessions where you can discuss your research and innovations with smart people.

Experts from various fields, including doctors, dietitians, nurses, physicians, pharmacists, academic researchers, and other healthcare professionals, will be present at Cardiology 2023. They talk about heart complications and failure, as well as the consequences and precautions that come with it. Also discussed are advanced technologies that aid in the reduction of heart disease in people.

Entitlements

Keynote speakers and Session speakers
Young Research Forum (YRF)
Delegates
Research findings and proposals
Exhibition of innovative products and devices related to the Cardiology 2023

Targeted Audience:

Conference Awards:

Cardiology 2023 is an international conference where people gather to exchange new ideas and learn about the most up-to-date methods for managing heart disease medications. This is a once-in-a-lifetime opportunity to bring together great people from all over the world who are experts in cardiology and can discuss research and innovations with brilliant minds through scientific sessions.

The most talented attendees will be recognized with awards such as Best Keynote Speaker, Best Organizing Committee Member, Best Speaker, Best Masters/Ph.D./Postdoc Thesis Work Presentation, and Best Poster Award. The speaker who presents their poster in an effective and understandable manner with all the details wins the poster presentation award. The best YRF award is given to young researchers who give an excellent speech on the topic, complete with all content and illustrations. The topic should be interesting, and the manner in which the information is delivered is also important. The best OCM award goes to members of the organizing committee who help and suggest ideas to make the conference a success.

Doctors, dietitians, nurses, surgeons, pharmacologists, academic researchers, and other healthcare professionals will be present at Cardiology 2023. They talk about heart diseases and the complications, consequences, and precautions that come with them. Also, advanced technologies aid in the reduction of heart conditions in people.

Registration and submission of abstracts

To participate in Cardiology 2023, you must submit an abstract for your chosen topic under the sessions section. You can register for the conference once your abstract has been accepted by the organizing committee.

For the submission of abstract: Abstract Submission Link
For Registration: Registration Link

Scientific Sessions

Session 1: Cardiovascular diseases and Disorders

Cardiovascular diseases involve the heart and blood vessels It is now the leading cause of death. heart disease is caused by age, sex, tobacco use, physical inactivity, excessive alcohol consumption, a poor diet, and obesity The main cause of heart attacks and strokes is a blood vessel blockage that prevents blood from flowing to the heart or brain. Chest pain, discomfort in the arms, left shoulder, elbows, jaw, or back, breathing difficulties, feeling sick, or vomiting is all symptoms. People who are experiencing these symptoms should seek medical help right away.

Some of the Cardiovascular diseases:

Cardiomyopathy
Hypertensive heart disease
Heart failure
Pulmonary heart disease
Cardiac dysrhythmias
Endocarditis-inflammation
Myocarditis
Vascular heart disease
Rheumatic heart disease
Coronary artery disease
Peripheral arterial disease
Aortic Aneurysm

Session 2: Pediatric cardiology

Pediatric cardiology is concerned with the diagnosis of congenital heart defects, the performance of diagnostic procedures such as echocardiograms, cardiac catheterization, and electrophysiology studies, as well as the ongoing management of heart disease in infants, children, and adolescents. Different types of inflammatory heart disease include myocarditis (the disease is characterized by heart muscle inflammation); Kawasaki's disease is a rare childhood disease that affects blood vessels. Acute pericarditis, pericardial effusion, cardiac tamponade, and constrictive pericarditis are all clinical terms for pericardial diseases. Endocarditis with infectious endocarditis is a type of endocarditis.

Cardiac Malformation
Congenital Abnormalities
Hypoplastic Left Heart Syndromes
Auditory Stimulation Therapy
Myocarditis

Session 3: Congenital heart disease

Congenital heart disease is a type of birth defect that affects the normal functioning of the heart. The term "congenital" refers to a condition that has existed since birth. Congenital heart disease is one of the most common birth defects, affecting nearly one in every 100 babies born in the United Kingdom. Congenital heart disease occurs when the heart's normal development is disrupted. The majority of cases are thought to occur when something interferes with the heart's development during the first six weeks of pregnancy.

Types of congenital heart disease,

septal defects
coarctation of the aorta
pulmonary valve stenosis
transposition of the great arteries
underdeveloped heart

Session 4: Interventional Cardiology

Interventional Cardiology is the treatment based on catheters for structural heart diseases. Cardiologists may use one or a combination of these techniques to identify and treat the patient’s heart condition.

Non-Invasive Cardiology
Interventional Cardiology
Coronary Intervention
Coronary Intervention: Complications
Coronary Intervention: Primary and Acute PCI
Coronary Intervention: Mechanical Circulatory Support
Coronary Intervention: Restenosis
Non-coronary Cardiac Intervention
Several specific new technologies are 3D printing; CTCA; FFR; Precision cardiology; Robotics; Stereolithography; VR; Virtual Reality.

Session 5: Sports Cardiology

Sports Cardiology is said with the cardiovascular care of athletes and exercise cardiology is said to the individuals of all age groups. Sports Cardiology also includes guts screening which helps to detect serious cardiovascular issues in young athletes. Sudden asystole is the leading cause of death in young athletes who are exercising. A malignant tachyarrhythmia, such as fibrillation (VF) or ventricular tachycardia deteriorating into VF, can trigger this. Due to the complex individual cardiovascular demands and adaptations forced by exercise, Cardiologists face a variety of challenges when evaluating athletes. The most aim of the Sports Cardiology Centre is to figure with any athlete forward the range -proficient athlete, recreational exercisers, to finish of the week warriors to enable them to realize these goals.

Improving ECG interpretation in athletes
Circadian rhythm
Cardiovascular assessment
Sports and disorder Patient-centred counseling
Cardiac exercise science
Exercise stress testing
Sudden cardiac death in sports
Cardiovascular epidemiology & population science

Session 6: Cardiac Surgery

Cardiac Surgery is the most familiar kind of heart medical practice for grown-ups as coronary artery bypass grafting (CABG). A solid course or vein from the body is linked to a blocked coronary (heart) artery during CABG. The bypassed portion of the coronary conduit is avoided by the merged supply route or vein. This provides an additional pathway for oxygen-rich blood to reach the heart muscle. CABG can relieve chest pain while also lowering the risk of coronary failure. Only in life-threatening situations is surgery recommended. The main goal of Cardiac Surgery is to improve the patient's life expectancy by improving heart function. These procedures are carried out by cardiothoracic or cardiac surgeons.

Cardiac Surgery and Arrhythmias
Cardiac Surgery and CHD and Paediatrics
Cardiac Surgery and Heart Failure
Cardiac Surgery and SIHD
Cardiac Surgery and VHD
Vascular Surgery
Coronary artery bypass grafting (CABG)
Heart valve repair or replacement
Pacemaker or implantable cardioverter-defibrillator implantation (ICD).Maze surgery
Aneurysm repair
Ventricular assist device (VAD) or total artificial heart implantation (TAH)Abdominal Surgery
Experimental Surgery
Aortic Surgery

Session 7: Heart Failure

Heart failure, often known as Congestive heart failure, is a condition where the heart muscle is unable to pump blood as efficiently as it should. Shortness of breath is frequently brought on by this because blood frequently backs up and fluid can accumulate in the lungs. The heart eventually becomes too weak or stiff to fill and pump blood adequately as a result of some heart disorders, such as coronary artery disease (coronary artery disease) or excessive blood pressure. With the right care, heart failure symptoms and signs can be reduced, and some people may even live longer.

People with heart failure may experience severe symptoms, and may even involve having a ventricular assist device or a heart transplant (VAD). Preventing and managing conditions like coronary artery disease, high blood pressure, Diabetes, and obesity that can lead to heart failure is one method to do so.

Left-side heart failure
Right-side heart failure
Systolic heart failure (also called as heart failure with reduced ejection fraction)
Heart failure with preserved ejection fraction

Session 8: Diabetes, obesity, and Heart

Diabetes and obesity are two important modifiable stroke risk factors. Diabetes patients have a higher risk of stroke and a worse prognosis after a stroke. In Diabetes and obesity, risk-factor modification is the most important aspect of stroke prevention. This entails lifestyle changes as well as various therapeutic modalities to manage conditions such as Diabetes, hypertension, dyslipidemia, and arrhythmia. Diabetes is curable, but it significantly increases the risk of heart disease and stroke even when glucose levels are under control. That's because people with Diabetes, specifically type2 Diabetes, may have the subsequent conditions that contribute to their risk for developing cardiovascular disease

Diabetes Mellitus and Stroke
Abnormal Cholesterol and High Triglycerides
Metabolic Syndrome
Sleep Apnea
SNP in Diabetes, obesity, and Heart
Risk Factors for Diabetes, Adiposity, and heart disease
Case Studies of Genetic Linkage

Session 9: Advanced Cardiovascular Imaging

Advanced cardiac imaging is diagnostic radiology that uses medical images to diagnose Cardiovascular diseases and to detect defects in the size and shape of the heart.

Clinical radiology
Pediatric Radiology
transthoracic echocardiogram - TTE
Cardiovascular magnetic resonance - CMR
A transoesophageal echocardiogram - TOE
Interventional Radiology and Cardiology
Cardiovascular Computed Tomography - CCT
Artificial Intelligence Enters CT Imaging
TAVR CT imaging
Congenital and Acquired Cardiovascular Disease 4D Flow Imaging

Session 10: Cardiac and Cardiovascular Research

Series of Cardiology Research exclusively focuses on bringing recent advances from the field that are authentic and medically proven. Cardiovascular health is improved by regular physical activity. Physical activity helps to keep blood pressure in check, improve insulin sensitivity, and maintain a healthy plasma lipoprotein profile. This annual cardiology meeting serves as a forum for postgraduate education and research in the fields of cardiology, angiology, hypertension, stroke, vascular surgery, cardiac medications, cardio health diet, and a variety of other topics. Endothelial dysfunction; Clinical assessment

NASH and other ectopic lipid diseases
Chronic kidney disease and nephropathies
Diabetes; macro- and microangiopathies
Nutrition, nutraceuticals
Bariatric surgery
Anti-thrombotic therapies
Anti-inflammatory therapies
Cardiovascular disease prevention and treatment; miscellaneous
New lipid-lowering therapies
Coagulation and Thrombosis

Session 11: Cardiac nursing

Cardiac nursing is concerned with preventing and treating heart problems. Nurses in the cardiac department work in inpatient or outpatient settings, care for medical or surgical patients, and understand patients through acute illness or help them manage chronic disease. Cardiac nurses help to treat disorders like unstable angina, arterial coronary disease, congestive coronary failure, myocardial infarct, and cardiac dysrhythmia under the direction of a cardiologist. They perform excellent care on a surgical unit; analyzing evaluations, cardiac monitoring, vascular monitoring, and health assessments. Basic and Advanced Cardiac Life Support certifications are readily accessible to cardiac nurses. In addition, cardiac nurses have specialized skills such as electrocardiogram monitoring, defibrillation, and continuous drip drug administration. Coronary care units, cardiac catheterization, medical care units, operating theatres, cardiac rehabilitation centers, clinical research, Cardiac Surgery wards, cardiovascular intensive care units, and cardiac medical wards are all places where cardiac nurses work.

Cardiac Nurse’s typical responsibilities include:
Evaluate and treat patients.
Provide postoperative care.
Monitor stress test evaluations.
Monitor cardiac and vascular readings.
Educate patients and their families.
Support and motivate patients' lifestyle changes

Session 12: Cardio Oncology

Cardio-oncology is the juncture of heart conditions in patients who have been cured of cancer. Cardiologists can evaluate patients for potential risk of acquiring heart conditions if patients take up types of cancer drugs or go after radiation treatment to the chest. They also help oncologists protect their patients during treatment by closely monitoring the heart and detecting heart problems early on.

Chemotherapy
Targeted Therapy
Cardiac Neoplasm
Nuclear Cardiology
Advanced Cancer Treatment
Cardiac Tumour

Session 13: Heart Devices

New cardiac technologies are being developed to monitor innovative devices and procedures for diagnosing and treating heart conditions.

Bioresorbable stents
Leadless pacemaker
Valve-in-valve procedure
Protein patch for heart muscle growth
Miniature Ventricular Assist Device
Novel Embolic Protection to Prevent Strokes
Organ Conformal Electronics
Mitral Valve Modulation and Repair
Cardiac Decellularization and Engineered Heart Tissue
Small, Portable ECMO Devices
Engineered Heart Valve
Artificial Intelligence to Predict Cardiac Arrhythmias
Magnetic Navigation and Robotic Systems
Pluripotent Stem Cells and Transdifferentiated Cardiomyocytes

Session 14: Nephro Cardiology

Infrequently used in the medical literature, nephro cardiology—or, in some cases, cardio nephrology—has implications primarily for the cardiorenal syndrome and cardiac effects of chronic kidney disease. Additionally, it has never been explicitly defined as a medical specialty with a certain scope, nor has it continuously conveyed the same denotation in its various appearances.

Nephrocardiology, the study of the interaction between nephrology and cardiovascular medicine, encompasses a wide range of subtleties that are not typically covered in either field of study. All Cardiologists and nephrologists ought to be knowledgeable about those subjects, and a "nephrocardiologist" needs to be an expert in them. In order to determine the best clinical solutions for this complexity and to learn more about the extent of those interactions, nephrologists should also direct new research.

Cardiorenal Syndrome
cardiac complications of CKD

Session 15: Cardiovascular Pharmacology

Cardiovascular pharmacology is concerned with drugs that are used in the treatment of Cardiovascular diseases. Medications are used to treat a variety of heart problems. The following are some examples of drugs used in cardiovascular medicine:

Anticoagulants or blood thinners
Antiplatelet agents
Thrombolytic agents
Angiotensin-converting enzyme (ACE) inhibitors
Angiotensin II receptor blockers (ARBs)
Diuretics
Calcium channel blockers
Vasodilators
Digoxin

Session 16: Cardiac regeneration

Cardiac regeneration is an effort to use cutting-edge science, such as stem cell and cell-free cell therapy, to repair irreversibly damaged heart tissue. The natural ability of the body to regenerate has been used to design reparative tools to restore damaged heart tissue and function.

Tissue engineering
Heart Regeneration in Lower Vertebrates
Limited Regeneration in Rodent Hearts
The Evidence for Human Heart Regeneration
Stem Cells and Cell Therapy
Reprogramming Fibroblasts to Cardiomyocytes

Session 17: Current Cardiology Research and Developments

Current Research in Cardiology: With the recent development of innovative techniques and devices, the management and treatment of Cardiovascular diseases have improved to a great extent saving numerous precious lives.

New guidelines on revascularization, new developments in the treatment of cardiogenic shock, novel stent technology, and clinical trial data showing no benefit of stopping aspirin after a stenting procedure are just a few of the major advances in cardiology.

Thrombolytic therapy
Cardiac rehabilitation
3-D imaging
Wearable technologies
Wireless technologies and biosensors
Percutaneous mitral valve repair devices
3-D bioprinting

Market Research

The overall cardiovascular therapeutics market remains to see an instant revolution with the latest drugs and devices emerging to the market. According to cardiovascular market study professionals, diabetes is one of the key components leading to the recent cardiovascular disease outbreak. The expanding prevalence of recurring diseases such as diabetes is the foremost factor leading to the progress of the heart failure market. Due to the impending breakthrough of newly approved drugs entering the marketplace, the heart failure market size is projected to expand in the forthcoming years.

The worldwide market for cardiovascular devices achieved nearly $42.4 billion in 2017 and should attain$59.1 billion by 2022, at a compound annual growth rate (CAGR) of 6.9% for the phase of 2017-2022. million deaths in Europe and over 1.8 million deaths in the European Union (EU). Moreover, other factors, such as the quick technological advances, improving awareness of the residents, and high-level preference for minimally invasive techniques are also enhancing the market growth. The cardiovascular disease market, which comprises numerous disorders like hypertension, cardiac arrest, dyslipidemia, coronary artery disorders, and thrombotic events, is established to cultivate from $129.2 billion in 2015 to$146.4 billion by 2022, at a very modest compound annual growth rate of 1.8%, according to business intelligence provider GBI Research. According to the European Heart Network, each year, cardiovascular disease (CVD) initiates 3.9

Regional Market Analysis

The China cardiovascular devices market was estimated at USD 2837.61 million in 2018, and it is likely to reach USD 4468.02 million by 2024, with a projected CAGR of 7.86% during the forecast period, 2019-2024. The expanding prevalence of cardiovascular diseases and the growing elderly population are the extremely significant circumstances leading to the growth of the market.

China’s population is aging at a quicker rate than virtually all other countries of the Asia-Pacific region, which is in part due to the long run of China’s one-child policy and remarkable expansion in healthcare amenities. According to government assessments, the senior population may point at more than 450 million senior citizens, by 2050.

The aging procedure is commonly linked with enhanced vascular firmness and diminished vascular compliance. Elderly patients have an elevated risk of developing cardiovascular conditions, such as peripheral arterial disease (PAD), aortic disease, and venous thromboembolism(VTE). This is principally due to age-related adjustments in vascular structure and rigidity, further compounded by longer coverage of cardiovascular disease(CVD) risk factors. Additionally, other factors, such as prompt technological advances, ever-increasing awareness of the population, and high-level preference for minimally-invasive processes, are also complementing the market growth.

CVD is not only the leading killer in the world but also the number one cause of death in China. In Beijing, the total loss of life expectancy due to CVD is projected at 317,813 person-years. That is, the loss of life per thousand persons is 24 person-years. Nevertheless, for critically ill patients, drugs have constraints. Under such as inherited defects, atherosclerosis induced by coronary artery disease, and acute heart valve diseases, patients ought to be treated more than that. Interventional medicines include PCI, bypass, open-heart cardiac surgery, heart transplantation, etc. In supplement to the total artificial heart, the supported artificial heart is more generally used. Three distinct kinds of devices, including left ventricular assist device (LVAD), right ventricular assist device (RVAD), and Bi-ventricular assist device (Bi-VAD) three, are utilized for various cases and conditions.

Metrices

See the Conference metrics for the "7th International Conference on Cardiology Heart Disease and Heart Failure". These Metrics are pointed to find how many new visitors using our website on a daily basis.